Skip to content Skip to Search
Skip navigation

Pharma giant Teva trims revenue estimates on currency volatility

By Reuters
Person, Human, Pill
Hurt by lower sales in North America of both generic drugs and its own multiple sclerosis treatment Copaxone, Teva revenue fell 8 percent to $3.66 billion.

Israel-based Teva Pharmaceutical Industries, which continues to forge legal settlements in US opioid cases, reported as expected first-quarter profit and trimmed 2022 revenue estimates due to currency fluctuations.

The world’s largest generic drugmaker said on Tuesday it earned 55 cents per diluted share excluding one-time items in the January-March period, down from 63 cents a share a year earlier.

Hurt by lower sales in North America of both generic drugs and its own multiple sclerosis treatment Copaxone, which is facing stiff competition, revenue fell 8 percent to $3.66 billion.

Analysts had forecast Teva would earn 55 cents a share ex-items on revenue of $3.76 billion, according to I/B/E/S data from Refinitiv.

Teva lowered its 2022 revenue estimate to $15.4-$16.0 billion from $15.6-$16.2 billion, after revenue of $15.9 billion in 2021. It reiterated its projection for 2022 adjusted EPS of $2.40-$2.60, versus $2.58 last year.

Teva said it paid $1.1 billion in the quarter for legal settlements and loss contingencies, while settling opioid cases in Florida and Rhode Island.

Sales of the company’s migraine drug Ajovy grew 16 percent to $36 million. Huntington’s disease treatment Austedo sales rose 6 percent to $154 million.

Overall generic drug sales in North America dipped 15 percent to $899 million due to competition on many products.

Revenue in Europe slipped 5 percent to $1.16 billion, although sales of Ajovy doubled to $30 million.

“While easing of Covid-19 related restrictions has led to positive momentum in our European business, we are seeing fluctuations of foreign exchange rates, and have therefore lowered our 2022 revenue outlook,” said CEO Kåre Schultz.

Latest articles

Shares in Spinneys are expected to begin trading in Dubai on May 9

Dubai’s Spinneys plans Egypt expansion with 10 new stores

Dubai’s supermarket operator Spinneys will open 10 new stores in Egypt as part of its expansion drive.  Four new stores will be opened before June 2024, while six more will be opened in fiscal year 2024/2025, which starts in July, Daily News Egypt reported. The company currently has 27 stores in Egypt. “Our vision for […]

A view of Jebel Ali Port. Trade between the UAE and India rose from $72.9 billion to $84.5 billion between 2021 and 2023

UAE and India on track to hit $100bn non-oil trade

The UAE and India will surpass the $100 billion non-oil trade target by 2030, with increasing aviation links between the two countries seen as a potential catalyst. Bilateral trade increased by 15 percent since the comprehensive economic partnership agreement (Cepa) was implemented in May 2022, the Indian government-owned Press Trust of India reported, quoting Cepa council director […]

The oil-for-cash deal with Dubai's HBK DOP represents twice South Sudan’s GDP, with 70% to be spent on infrastructure

Dubai company in $13bn oil-for-cash deal with South Sudan

Dubai-based Hamad Bin Khalifa Department of Projects (HBK DOP) has signed a €12 billion ($12.9 billion) oil-for-cash deal with South Sudan, according to a media report. The loan agreement was finalised between HBK DOP and South Sudan’s former finance minister Bak Barnaba Chol between December and February, Bloomberg reported, citing an unpublished report by a United […]

Al Maktoum International Airport will be able to handle 260m passengers annually

First phase of Dubai’s $35bn airport to be ready in 10 years

Dubai has launched the world’s largest passenger terminal at Al Maktoum International at a cost of AED128 billion ($34.85 billion), capable of handling 260 million passengers annually upon completion. The initial phase of the project, slated to be completed within a decade, will be able to accommodate 150 million passengers annually, the UAE state-run Wam […]